<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100505003871N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-22</date_registration>
      <primary_sponsor>Bagheiat-allah University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of Telerehabilitation exercises in elderly chemical veterans</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of Telerehabilitation exercises on quality of life, balance, functional disability, aerobic capacity and pain in elderly chemical veterans</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86846</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: To randomize participants into two groups, control and intervention, a block randomization method will be used with the help of Excel software. The allocation sequence will be generated with the help of the software's random functions (RAND) and participants will be placed equally and randomly in two groups in blocks of four. The final allocation will be made by someone outside the implementation team and through prepared lists to prevent any bias. Measures will be taken to control and reduce possible measurement errors in the pre-test and post-test stages. All tests will be performed by a fixed and trained examiner to prevent errors.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic complications of chemical warfare exposure (elderly chemical veterans).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The group's exercises will be performed three days a week for 8 weeks. The video exercise program will be provided through web-based platforms such as Telegram or WhatsApp. First, the researcher will perform each exercise personally and provide the necessary explanations during the exercise. Then, the video of this performance will be made available to the subjects, and after each exercise session, the subjects will send the video of the exercise performance to the researcher. The exercise program of the intervention group will include the following steps: Warm-up (5-7 minutes) / Aerobic exercises (10-12 minutes) / Strength exercises (10-12 minutes) / Balance and flexibility exercises (8-10 minutes) / Relaxation and cooling down (3-5 minutes). Participants are required to complete the weekly monitoring form. This form includes the following: Days of exercise / Type of exercise performed (aerobic, strength, balance, stretching) Approximate duration of exercise / Physical feeling after exercise (comfort, fatigue, pain, etc.) Obstacles or problems in performing the exercises. Participation in at least 75% of training sessions is considered acceptable adherence. Intervention 2: Control group: During the eight-week intervention, participants in the control group will continue their normal daily activities. They are allowed to do light activities such as walking or housework but should not participate in any structured exercise or rehabilitation program. Weekly monitoring will be done by telephone, and if interventions similar to the main intervention are initiated, the subject's continued participation in the study will be reviewed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Shamsoddini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Physiology Research Institute, Bagheiat-allah University of Medical Sciences, South Sheikh bahai St., Mollla Sadra St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435916471</zip>
        <telephone>+98 21 8248 3353</telephone>
        <email>alirezaot@bmsu.ac.ir</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Shamsoddini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Physiology Research Institute, Bagheiat-allah University of Medical Sciences, South Sheikh bahai St., Mollla Sadra St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1435916471</zip>
        <telephone>+98 21 8248 3353</telephone>
        <email>alirezaot@bmsu.ac.ir</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male chemical veterans over 60 years of age with a proven history of exposure to mustard gas
Participants must have moderate to severe chronic lung disease.</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Participants had a history of tuberculosis or resection of 1 or more lung lobes.
No history of exposure to mustard gas is recorded in the Veterans Foundation's medical file.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T59.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Toxic effect of chlorine gas</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The group's exercises will be performed three days a week for 8 weeks. The video exercise program will be provided through web-based platforms such as Telegram or WhatsApp. First, the researcher will perform each exercise personally and provide the necessary explanations during the exercise. Then, the video of this performance will be made available to the subjects, and after each exercise session, the subjects will send the video of the exercise performance to the researcher. The exercise program of the intervention group will include the following steps: Warm-up (5-7 minutes) / Aerobic exercises (10-12 minutes) / Strength exercises (10-12 minutes) / Balance and flexibility exercises (8-10 minutes) / Relaxation and cooling down (3-5 minutes). Participants are required to complete the weekly monitoring form. This form includes the following: Days of exercise / Type of exercise performed (aerobic, strength, balance, stretching) Approximate duration of exercise / Physical feeling after exercise (comfort, fatigue, pain, etc.) Obstacles or problems in performing the exercises. Participation in at least 75% of training sessions is considered acceptable adherence.</i_keyword>
      <i_keyword>Control group: During the eight-week intervention, participants in the control group will continue their normal daily activities. They are allowed to do light activities such as walking or housework but should not participate in any structured exercise or rehabilitation program. Weekly monitoring will be done by telephone, and if interventions similar to the main intervention are initiated, the subject's continued participation in the study will be reviewed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Comparison of Quality-of-life scores in the control and intervention groups. Timepoint: At baseline and after eight weeks of intervention. Method of measurement: SF-36 Quality of Life Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Comparison of balance scores in the control and intervention groups. Timepoint: At baseline and after eight weeks of intervention. Method of measurement: Sharpened Romberg Test.</sec_outcome>
      <sec_outcome>Comparison of functional disability scores in the control and intervention groups. Timepoint: At baseline and after eight weeks of intervention. Method of measurement: Oswestry Disability Index.</sec_outcome>
      <sec_outcome>Comparison of aerobic capacity scores in the control and intervention groups. Timepoint: At baseline and after eight weeks of intervention. Method of measurement: 6-Minute Walk Test.</sec_outcome>
      <sec_outcome>Comparison of pain scores in the control and intervention groups. Timepoint: At baseline and after eight weeks of intervention. Method of measurement: Visual Analogue Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bagheiat-allah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-06</approval_date>
        <contact_name>Ethics committee of Bagheiat-allah University of Medical sciences</contact_name>
        <contact_address>Sports Physiology Research Institute, Bagheiat-allah University of Medical sciences, South Sheikh Bahai St., Molla Sadra St. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
